_xsnx-discusses-pr-moneytv-with-donald-baillargeon-preview-1.jpg "XSNX Discusses PR- MoneyTV with Donald Baillargeon from xsnx Video Screenshot Preview 1")
Gallery_xsnx-discusses-pr-moneytv-with-donald-baillargeon-preview-3.jpg "XSNX Discusses PR- MoneyTV with Donald Baillargeon from xsnx Video Screenshot Preview 3")
Gallery_xsnx-discusses-pr-moneytv-with-donald-baillargeon-preview-hqdefault.jpg "XSNX Discusses PR- MoneyTV with Donald Baillargeon from xsnx Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 42 seconds
👁 View: 8 times
Play Audio:👁 View: 8 times
Description:
MoneyTV with Donald Baillargeon
MoneyTV with Donald Baillargeon
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_xsnx-progress-moneytv-with-donald-baillargeon.webp "On MoneyTV with Donald Baillargeon, NovAccess Global, Inc. (OTCPINK: XSNX) CEO Dr. Dwain Irvin reported on company progress from the LD Micro Conference.")
_xsnx-funding-moneytv-with-donald-baillargeon.webp "MoneyTV with Donald Baillargeon")
_orphan-drug-status-moneytv-with-donald-baillargeon.webp "On MoneyTV with Donald Baillargeon, NovAccess Global, Inc. (OTCQB: XSNX) CEO Dr. Dwain Irvin announced their treatment has achieved orphan drug status with the FDA.")
_kirkiimad-ily-xsnx-mscx-remix.webp "XSNX MSCX")
_xsnx39s-thin-film-solar-technology-moneytv-with-donald-baillargeon.webp "MoneyTV with Donald Baillargeon")
_xsnx-progress-moneytv-with-donald-baillargeon.jpg)
_xsnx-funding-moneytv-with-donald-baillargeon.jpg)
_orphan-drug-status-moneytv-with-donald-baillargeon.jpg)
_kirkiimad-ily-xsnx-mscx-remix.jpg)
_xsnx39s-thin-film-solar-technology-moneytv-with-donald-baillargeon.jpg)
![[+]](/images/menu.gif){kind=small}